CNTA - Centessa Pharmaceuticals GAAP EPS of -$0.26 August, 14 2023 09:56 AM Centessa Pharmaceuticals plc 2023-08-14 09:56:13 ET Centessa Pharmaceuticals press release ( NASDAQ: CNTA ): Q2 GAAP EPS of -$0.26. Cash, Cash Equivalents and Short-term Investments: $303.6 million as of June 30, 2023. For further details see: Centessa Pharmaceuticals GAAP EPS of -$0.26